| Ytd | 20.10% | |
| 1y | -25.94% |
| Open | 7.10 | Prev Close | 7.07 | Low | 7.07 | High | 7.25 | Mkt Cap | 230.35M |
| Vol | 83.73K | Avg Vol | 1.93M | EPS | -1.34 | P/E | -5.28 | Forward P/E | -1.40 |
| Beta | 3.35 | Short Ratio | 1.37 | Inst. Own | 66.94% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 7.13 | 200-d Avg | 6.60 | 1yr Est | 29.14 |
Sagimet Biosciences Inc. (NASDAQ:SGMT), a clinical-stage biopharmaceutical company developing novel
US stock futures up, Nasdaq futures 1% higher. Legend Biotech (LEGN) priced 7.7 million ADSs at $29.
On Thursday, 369 companies hit new 52-week lows.
On Wednesday, 311 stocks hit new 52-week lows.
On Monday, 369 companies set new 52-week lows.
On Tuesday, 386 stocks made new 52-week lows.